In vivo shear flow and erythrocyte membrane fluidity in hypertensive patients. 1993

K H Le Sang Quan, and J Levenson, and M Del Pino, and A Simon, and M A Devynck
CNRS URA 1482, Pharmacologie, Faculté de Médecine Necker-Enfants Malades, 75015 Paris, France.

1. To evaluate the response of red blood cells subjected to the shear flow in hypertension, the relationships between wall shear phenomena determined in vivo in the brachial artery of hypertensive patients and the modifications of the membrane dynamics measured in vitro in erythrocyte ghosts of 32 patients were investigated. 2. Two fluorescent probes, diphenylhexatriene (DPH) and its trimethylamino-derivative (TMA-DPH), localized respectively in the lipid membrane core and at the lipid-water interface, were used. 3. Shear rate, shear stress and blood velocity were positively correlated with TMA-DPH anisotropy (P = 0.015, 0.005 and 0.026, respectively), but not with that of DPH. This indicates that wall shear forces were associated with the microviscosity of the outer part of the cell membrane. 4. The changes in wall shear forces and erythrocyte membrane microviscosity probed by TMA-DPH or DPH were observed to vary in parallel under nitrendipine therapy. 5. These results suggest that in vivo shear forces participate in the control of erythrocyte membrane fluidity or that erythrocytes adapt their membrane properties to blood flow conditions.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008560 Membrane Fluidity The motion of phospholipid molecules within the lipid bilayer, dependent on the classes of phospholipids present, their fatty acid composition and degree of unsaturation of the acyl chains, the cholesterol concentration, and temperature. Bilayer Fluidity,Bilayer Fluidities,Fluidities, Bilayer,Fluidities, Membrane,Fluidity, Bilayer,Fluidity, Membrane,Membrane Fluidities
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001783 Blood Flow Velocity A value equal to the total volume flow divided by the cross-sectional area of the vascular bed. Blood Flow Velocities,Flow Velocities, Blood,Flow Velocity, Blood,Velocities, Blood Flow,Velocity, Blood Flow
D004161 Diphenylhexatriene A fluorescent compound that emits light only in specific configurations in certain lipid media. It is used as a tool in the study of membrane lipids. 1,6-Diphenyl-1,3,5-hexatriene,1,6-Diphenylhexatriene,1,6 Diphenylhexatriene
D004910 Erythrocyte Membrane The semi-permeable outer structure of a red blood cell. It is known as a red cell 'ghost' after HEMOLYSIS. Erythrocyte Ghost,Red Cell Cytoskeleton,Red Cell Ghost,Erythrocyte Cytoskeleton,Cytoskeleton, Erythrocyte,Cytoskeleton, Red Cell,Erythrocyte Cytoskeletons,Erythrocyte Ghosts,Erythrocyte Membranes,Ghost, Erythrocyte,Ghost, Red Cell,Membrane, Erythrocyte,Red Cell Cytoskeletons,Red Cell Ghosts
D005260 Female Females
D005456 Fluorescent Dyes Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. Flourescent Agent,Fluorescent Dye,Fluorescent Probe,Fluorescent Probes,Fluorochrome,Fluorochromes,Fluorogenic Substrates,Fluorescence Agents,Fluorescent Agents,Fluorogenic Substrate,Agents, Fluorescence,Agents, Fluorescent,Dyes, Fluorescent,Probes, Fluorescent,Substrates, Fluorogenic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

K H Le Sang Quan, and J Levenson, and M Del Pino, and A Simon, and M A Devynck
January 1985, Nephron,
K H Le Sang Quan, and J Levenson, and M Del Pino, and A Simon, and M A Devynck
October 1997, European journal of pharmacology,
K H Le Sang Quan, and J Levenson, and M Del Pino, and A Simon, and M A Devynck
July 2001, European journal of pharmacology,
K H Le Sang Quan, and J Levenson, and M Del Pino, and A Simon, and M A Devynck
December 2010, Acta diabetologica,
K H Le Sang Quan, and J Levenson, and M Del Pino, and A Simon, and M A Devynck
November 1991, Biochimica et biophysica acta,
K H Le Sang Quan, and J Levenson, and M Del Pino, and A Simon, and M A Devynck
February 1981, Rinsho byori. The Japanese journal of clinical pathology,
K H Le Sang Quan, and J Levenson, and M Del Pino, and A Simon, and M A Devynck
August 1989, Bollettino della Societa italiana di biologia sperimentale,
K H Le Sang Quan, and J Levenson, and M Del Pino, and A Simon, and M A Devynck
March 1995, Clinica chimica acta; international journal of clinical chemistry,
K H Le Sang Quan, and J Levenson, and M Del Pino, and A Simon, and M A Devynck
December 2019, Experimental gerontology,
K H Le Sang Quan, and J Levenson, and M Del Pino, and A Simon, and M A Devynck
May 1986, Diabetes,
Copied contents to your clipboard!